Melanoma: Clinical practice guidelines in oncology™

Alan N. Houghton*, Daniel G. Coit, Adil Daud, Raza A. Dilawari, Dominick DiMaio, Jared A. Gollob, Naomi B. Haas, Allan Halpern, Timothy M. Johnson, Mohammed Kashani-Sabet, William G. Kraybill, Julie R. Lange, Mary Martini, Merrick I. Ross, Wolfram E. Samlowski, Stephen F. Sener, Kenneth K. Tanabe, John A. Thompson, Vijay Trisal, Marshall M. UristMichael J. Walker

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


These guidelines represent an effort to distill and simplify an enormous body of knowledge and experience into fairly simple management algorithms. In general, treatment recommendations for primary tumors are based on better data than those for recurrent disease. Few, if any, firm recommendations can be made for patients with melanoma regarding more controversial issues, such as the extent of workup or intensity of follow-up. These guidelines are intended as a point of departure, recognizing that all clinical decisions about individual patient management must be tempered by the clinician's judgment and other factors, such as local resources and expertise, and the patient's needs, wishes, and expectations. Furthermore, these guidelines are revised annually and continually as new data become available.

Original languageEnglish (US)
Pages (from-to)666-684
Number of pages19
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number7
StatePublished - Aug 2006


  • Adjuvant therapy
  • Biopsy
  • Chemotherapy
  • Interferon
  • Melanoma
  • Metastases
  • NCCN Clinical Practice Guidelines
  • Radiation therapy
  • Sentinel lymph node
  • Skin cancer
  • Surgical excision

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Melanoma: Clinical practice guidelines in oncology™'. Together they form a unique fingerprint.

Cite this